![Viviane Monges](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Viviane Monges
Directeur/Membre du Conseil chez
PHARVARIS N.V.
Fortune : 2 M $ au 31/07/2026
Profil
Viviane Monges currently serves as Independent Director at bioMérieux SA since 2024, Director at Novo Holdings A since 2018, Independent Director at Voluntis SA, Independent Non-Executive Director at ADC Therapeutics SA since 2021, Independent Non-Executive Director at Pharvaris NV since 2021, Director at ADC Technologies, Inc., Director at Ferring BV, and Member-Strategic Board at NeoMedLight SAS since 2014.
Former roles include Chairman at EUROAPI SA from 2021 to 2024, Independent Director at UCB SA, Director at Ferring Holding SA, Independent Director at DBV Technologies SA from 2019 to 2022, Non-Executive Director at Idorsia Ltd. from 2018 to 2021, CFO-Global Pharmaceutical Business at Pfizer Inc. from 2004 to 2006, CFO-Business Excellence Division at Nestlé SA from 2015 to 2017, Global Chief Financial Officer at Novartis AG from 2008 to 2010, Chief Financial Officer at Galderma International SAS, CFO-Business Excellence Division at Nestlé Belgilux SA, Global CFO-Over-the-Counter Division at Novartis Pharma NV from 2008 to 2010, CFO-Global Pharma Business Unit at Wyeth Pharmaceuticals (Belgium) from 2004 to 2006, Group Chief Financial Officer at Galderma Holding SA from 2010 to 2015, and Head-Finance at Renault Asia Pacific Ltd. Education includes undergraduate and MBA degrees from ESCP Europe Campus Paris.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARVARIS N.V. 0,06 % | 21/05/2026 | 45 238 ( 0,06 % ) | 1 M $ | 31/07/2026 |
ADC THERAPEUTICS LTD 0,15 % | 03/06/2026 | 186 447 ( 0,15 % ) | 195 769 $ | 31/07/2026 |
Postes actifs de Viviane Monges
| Sociétés | Poste | Début |
|---|---|---|
| VOLUNTIS S.A. | Directeur/Membre du Conseil | - |
| ADC THERAPEUTICS SA | Directeur/Membre du Conseil | 11/06/2021 |
| PHARVARIS N.V. | Directeur/Membre du Conseil | 29/06/2021 |
| BIOMÉRIEUX | Directeur/Membre du Conseil | 23/05/2024 |
Ferring BV
 Ferring BV BiotechnologyHealth Technology Operates as a biopharmaceutical organization that develops reproductive, maternal health, gastroenterology and urology medicine | Directeur/Membre du Conseil | - |
ADC Technologies, Inc.
 ADC Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides IT consulting services | Directeur/Membre du Conseil | - |
Novo Holdings A/S (Denmark)
 Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Directeur/Membre du Conseil | 01/01/2018 |
NeoMedLight SAS
 NeoMedLight SAS Medical SpecialtiesHealth Technology Develops medical devices of phototherapy. | Corporate Officer/Principal | 01/01/2014 |
Anciens postes connus de Viviane Monges
| Sociétés | Poste | Fin |
|---|---|---|
| EUROAPI | Directeur Général | 01/03/2024 |
| ░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Viviane Monges
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Nestlé SA
 Nestlé SA Food: Major DiversifiedConsumer Non-Durables Produces, supplies and markets chocolates, frozen food, ice creams, dairy products and pet food | Consumer Non-Durables |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Novo Holdings A/S (Denmark)
Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
bioMérieux SA
 bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
Ferring Holding SA
 Ferring Holding SA Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops and markets pharmaceutical products for reproductive, maternal health & urology | Health Technology |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Researches, develops and markets therapeutic and aesthetic solutions for dermatology | Health Technology |
ESCP Europe Campus Paris
 ESCP Europe Campus Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nestlé Belgilux SA
 Nestlé Belgilux SA Food: Meat/Fish/DairyConsumer Non-Durables Produces dairy products | Consumer Non-Durables |
Novartis Pharma NV
 Novartis Pharma NV Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Voluntis SA
 Voluntis SA Packaged SoftwareTechnology Services Develops anti-cancer treatment platform | Technology Services |
Ferring BV
Ferring BV BiotechnologyHealth Technology Operates as a biopharmaceutical organization that develops reproductive, maternal health, gastroenterology and urology medicine | Health Technology |
Wyeth Pharmaceuticals (Belgium) | |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Galderma Holding SA
 Galderma Holding SA Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and distributes dermatological & skin care products | Health Technology |
NeoMedLight SAS
NeoMedLight SAS Medical SpecialtiesHealth Technology Develops medical devices of phototherapy. | Health Technology |
Renault Asia Pacific Ltd. | |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
ADC Technologies, Inc.
ADC Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides IT consulting services | Commercial Services |
EUROAPI SA
 EUROAPI SA BiotechnologyHealth Technology Develops, manufactures, markets and distributes small molecule APIs | Health Technology |
